Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 200

1.

Protozoan parasite aquaporins.

Fadiel A, Isokpehi RD, Stambouli N, Hamza A, Benammar-Elgaaied A, Scalise TJ.

Expert Rev Proteomics. 2009 Apr;6(2):199-211. doi: 10.1586/epr.09.10. Review.

PMID:
19385945
2.

ABC transporters and drug resistance in parasitic protozoa.

Klokouzas A, Shahi S, Hladky SB, Barrand MA, van Veen HW.

Int J Antimicrob Agents. 2003 Sep;22(3):301-17. Review.

PMID:
13678838
3.
4.

Novel therapeutic targets in Plasmodium falciparum: aquaglyceroporins.

Kun JF, de Carvalho EG.

Expert Opin Ther Targets. 2009 Apr;13(4):385-94. doi: 10.1517/14728220902817839 . Review.

PMID:
19335062
5.

Limited genetic diversity of the Plasmodium falciparum aquaglyceroporin gene.

Bahamontes-Rosa N, Wu B, Beitz E, Kremsner PG, Kun JF.

Mol Biochem Parasitol. 2007 Dec;156(2):255-7. Epub 2007 Aug 7.

PMID:
17850897
6.

PfEMP1: an antigen that plays a key role in the pathogenicity and immune evasion of the malaria parasite Plasmodium falciparum.

Pasternak ND, Dzikowski R.

Int J Biochem Cell Biol. 2009 Jul;41(7):1463-6. doi: 10.1016/j.biocel.2008.12.012. Epub 2008 Dec 25. Review.

PMID:
19150410
7.

Evolutionary patterning: a novel approach to the identification of potential drug target sites in Plasmodium falciparum.

Durand PM, Naidoo K, Coetzer TL.

PLoS One. 2008;3(11):e3685. doi: 10.1371/journal.pone.0003685. Epub 2008 Nov 10.

8.

Protein-drug interaction studies for development of drugs against Plasmodium falciparum.

de Azevedo WF Jr, Caceres RA, Pauli I, Timmers LF, Barcellos GB, Rocha KB, Soares MB.

Curr Drug Targets. 2009 Mar;10(3):271-8. Review.

PMID:
19275563
9.

Protein export from Plasmodium parasites.

van Ooij C, Haldar K.

Cell Microbiol. 2007 Mar;9(3):573-82. Epub 2007 Jan 11. Review. Erratum in: Cell Microbiol. 2007 Apr;9(4):1086.

PMID:
17223924
10.

Genome-scale protein expression and structural biology of Plasmodium falciparum and related Apicomplexan organisms.

Vedadi M, Lew J, Artz J, Amani M, Zhao Y, Dong A, Wasney GA, Gao M, Hills T, Brokx S, Qiu W, Sharma S, Diassiti A, Alam Z, Melone M, Mulichak A, Wernimont A, Bray J, Loppnau P, Plotnikova O, Newberry K, Sundararajan E, Houston S, Walker J, Tempel W, Bochkarev A, Kozieradzki I, Edwards A, Arrowsmith C, Roos D, Kain K, Hui R.

Mol Biochem Parasitol. 2007 Jan;151(1):100-10. Epub 2006 Nov 13.

PMID:
17125854
11.

Tropical infectious diseases: metabolic maps and functions of the Plasmodium falciparum apicoplast.

Ralph SA, van Dooren GG, Waller RF, Crawford MJ, Fraunholz MJ, Foth BJ, Tonkin CJ, Roos DS, McFadden GI.

Nat Rev Microbiol. 2004 Mar;2(3):203-16. Review. No abstract available.

PMID:
15083156
12.

A polymorphic drug pump in the malaria parasite.

Saliba KJ, Lehane AM, Kirk K.

Mol Microbiol. 2008 Nov;70(4):775-9. doi: 10.1111/j.1365-2958.2008.06451.x.

13.

15-deoxyspergualin primarily targets the trafficking of apicoplast proteins in Plasmodium falciparum.

Ramya TN, Karmodiya K, Surolia A, Surolia N.

J Biol Chem. 2007 Mar 2;282(9):6388-97. Epub 2006 Dec 28.

14.

The ferredoxin-NADP+ reductase/ferredoxin electron transfer system of Plasmodium falciparum.

Balconi E, Pennati A, Crobu D, Pandini V, Cerutti R, Zanetti G, Aliverti A.

FEBS J. 2009 Jul;276(14):3825-36. doi: 10.1111/j.1742-4658.2009.07100.x. Epub 2009 Jun 11.

15.

Molar concentrations of sorbitol and polyethylene glycol inhibit the Plasmodium aquaglyceroporin but not that of E. coli: involvement of the channel vestibules.

Song J, Almasalmeh A, Krenc D, Beitz E.

Biochim Biophys Acta. 2012 May;1818(5):1218-24. doi: 10.1016/j.bbamem.2012.01.025. Epub 2012 Feb 2.

16.

Chloroquine transport via the malaria parasite's chloroquine resistance transporter.

Martin RE, Marchetti RV, Cowan AI, Howitt SM, Bröer S, Kirk K.

Science. 2009 Sep 25;325(5948):1680-2. doi: 10.1126/science.1175667.

17.

Molecular dissection of water and glycerol permeability of the aquaglyceroporin from Plasmodium falciparum by mutational analysis.

Beitz E, Pavlovic-Djuranovic S, Yasui M, Agre P, Schultz JE.

Proc Natl Acad Sci U S A. 2004 Feb 3;101(5):1153-8. Epub 2004 Jan 20.

18.

Discovery of dual function acridones as a new antimalarial chemotype.

Kelly JX, Smilkstein MJ, Brun R, Wittlin S, Cooper RA, Lane KD, Janowsky A, Johnson RA, Dodean RA, Winter R, Hinrichs DJ, Riscoe MK.

Nature. 2009 May 14;459(7244):270-3. doi: 10.1038/nature07937. Epub 2009 Apr 8.

PMID:
19357645
19.

Estimating novel potential drug targets of Plasmodium falciparum by analysing the metabolic network of knock-out strains in silico.

Fatumo S, Plaimas K, Mallm JP, Schramm G, Adebiyi E, Oswald M, Eils R, König R.

Infect Genet Evol. 2009 May;9(3):351-8. doi: 10.1016/j.meegid.2008.01.007. Epub 2008 Jan 20.

PMID:
18313365
20.

Antimalarial effect of N-acetyl-L-Leucyl-L-leucyl-L-norleucinal by the inhibition of Plasmodium falciparum Calpain.

Jung SY, Zheng B, Choi YY, Soh BY, Kim SY, Park KI, Park H.

Arch Pharm Res. 2009 Jun;32(6):899-906. doi: 10.1007/s12272-009-1612-4. Epub 2009 Jun 26.

PMID:
19557368
Items per page

Supplemental Content

Write to the Help Desk